Renal Cancer - Results from #260

Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma. July 16, 2024

Failure of the PD-1 Blocking Agent Pembrolizumab to Benefit a Patient with Renal Squamous Cell Cancer. July 16, 2024

Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma. July 15, 2024

Influence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell carcinoma. July 15, 2024

Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi-institutional analysis. July 12, 2024

Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney. July 12, 2024

Comparison of the Efficacy and Safety of Nivolumab Plus Cabozantinib versus Sunitinib in the Treatment of Elderly Patients with Advanced Clear Cell Renal Cell Carcinoma. July 11, 2024

High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and grades. July 11, 2024

Prognostic Impact of the Administration of Antibiotics and Proton Pump Inhibitors in Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma. July 10, 2024

Impact of Targeted Systemic Therapy and Radiotherapy on Patients Undergoing Spine Surgery for Metastatic Renal Cell Carcinoma. July 10, 2024

Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma. July 10, 2024

Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry. July 9, 2024

Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review. July 9, 2024

Stage IA papillary and chromophobe renal cell carcinoma: effectiveness of cryoablation and partial nephrectomy. July 8, 2024

Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with cT1-ccRCC After Partial Nephrectomy: A Multicenter Retrospective Study. July 8, 2024

Niraparib for the treatment of metastatic ccRCC in a patient with CDK12 and RAD51C mutations: a case report. July 5, 2024

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. July 5, 2024

Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010. July 4, 2024

A Nomogram Including Sarcopenia for Predicting Progression-Free Survival in Patients with Localized Papillary Renal Cell Carcinoma: A Retrospective Cohort Study. July 4, 2024

Incidence and predictors of ipsilateral local recurrence following partial nephrectomy. July 3, 2024

Page 14 of 456